Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 11.86
+0.11 (0.94%)
Feb 4, 2026, 2:55 PM CST
SHA:603998 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 295.36 | 255.22 | 186.82 | 285.85 | 70.04 | 63.79 |
Depreciation & Amortization | 75.7 | 75.7 | 74.21 | 78.3 | 78.36 | 70.45 |
Other Amortization | 9.15 | 9.15 | 7.34 | 9.82 | 11.36 | 9.23 |
Loss (Gain) From Sale of Assets | -0.75 | -0.75 | -11.53 | 0.9 | 0.07 | -0 |
Asset Writedown & Restructuring Costs | 5.43 | 5.43 | 0.28 | 1.31 | 12.81 | 6.08 |
Loss (Gain) From Sale of Investments | -37.74 | -37.74 | 5.46 | -166.18 | 9.46 | 18.73 |
Provision & Write-off of Bad Debts | -0.81 | -0.81 | 1.18 | 22.6 | 4.66 | - |
Other Operating Activities | 96.43 | 28.69 | 6.79 | 13.81 | 18.27 | 6.66 |
Change in Accounts Receivable | -54.61 | -54.61 | -78.93 | 196.46 | -62.47 | -26.48 |
Change in Inventory | -62.36 | -62.36 | -24.99 | -46.67 | -46.68 | -4.01 |
Change in Accounts Payable | -30.74 | -30.74 | -86.56 | -114.65 | 87.4 | 82.68 |
Change in Other Net Operating Assets | 3.4 | 3.4 | 18.23 | 12.19 | - | -2.84 |
Operating Cash Flow | 302.84 | 194.95 | 87.54 | 301.63 | 185.63 | 236.66 |
Operating Cash Flow Growth | 40.18% | 122.70% | -70.98% | 62.49% | -21.57% | 45.57% |
Capital Expenditures | -78.84 | -94.79 | -218.78 | -171.25 | -184.71 | -167.76 |
Sale of Property, Plant & Equipment | 27.44 | 28.95 | 9.21 | 1.86 | 0.06 | 0.04 |
Cash Acquisitions | - | - | 2.33 | -27.56 | -108.52 | - |
Divestitures | 26.62 | 22.89 | - | -19.41 | 14.31 | - |
Investment in Securities | 50.12 | 20.85 | 5.59 | -100.51 | 59.71 | -9.09 |
Other Investing Activities | 43.06 | 1.14 | 1.25 | 2.71 | -10.88 | 1.72 |
Investing Cash Flow | 130.4 | 41.04 | -197.4 | -301.49 | -230.03 | -174.15 |
Short-Term Debt Issued | - | - | - | 195.08 | - | - |
Long-Term Debt Issued | - | 906.66 | 498.9 | 735 | 530.41 | 459.28 |
Total Debt Issued | 621.6 | 906.66 | 498.9 | 930.08 | 530.41 | 459.28 |
Long-Term Debt Repaid | - | -887.16 | -389.77 | -695.3 | -501.73 | -326.39 |
Total Debt Repaid | -807.72 | -887.16 | -389.77 | -695.3 | -501.73 | -326.39 |
Net Debt Issued (Repaid) | -186.12 | 19.51 | 109.13 | 234.78 | 28.68 | 132.89 |
Issuance of Common Stock | - | - | 3.33 | 32.26 | - | - |
Repurchase of Common Stock | -1.53 | -1.53 | -1.89 | -2.63 | - | - |
Common Dividends Paid | -216.59 | -129.5 | -174.41 | -123.68 | -46.82 | -68.55 |
Other Financing Activities | -38.42 | -10.47 | -27.7 | -14.15 | 4.02 | 36.89 |
Financing Cash Flow | -442.66 | -122 | -91.55 | 126.58 | -14.13 | 101.23 |
Foreign Exchange Rate Adjustments | -0.02 | - | 0 | -0 | - | - |
Net Cash Flow | -9.45 | 113.99 | -201.41 | 126.71 | -58.53 | 163.75 |
Free Cash Flow | 224 | 100.16 | -131.24 | 130.38 | 0.92 | 68.9 |
Free Cash Flow Growth | 115.22% | - | - | 14138.22% | -98.67% | - |
Free Cash Flow Margin | 13.31% | 5.63% | -8.06% | 7.28% | 0.06% | 5.39% |
Free Cash Flow Per Share | 0.51 | 0.23 | -0.29 | 0.30 | 0.00 | 0.16 |
Cash Interest Paid | 0.23 | 0.23 | 0.36 | 0.42 | 0.35 | - |
Cash Income Tax Paid | 195.96 | 199.83 | 190.24 | 177.97 | 171.02 | 83.15 |
Levered Free Cash Flow | 109.83 | 16.94 | 23.32 | -166.94 | 163.97 | -10.85 |
Unlevered Free Cash Flow | 120.64 | 30.56 | 36.32 | -152.6 | 175.47 | -0.33 |
Change in Working Capital | -139.94 | -139.94 | -183.02 | 55.22 | -19.41 | 49.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.